Literature DB >> 14744589

Visual electrophysiological screening in diagnosing infants with congenital nystagmus.

Jelka Brecelj1, Branka Stirn-Kranjc.   

Abstract

OBJECTIVE: To determine the value of visual electrophysiological screening in evaluating retinal and postretinal visual pathway function in infants with congenital nystagmus.
METHODS: In 28 infants with congenital nystagmus electroretinogram (ERG) was recorded with skin electrodes and, since the infants were alert, visual evoked potentials (VEP) were simultaneously recorded. The first recording was performed before the age of 1 year (age 2-11 months, mean age 6.8 months). Follow-up was performed between the ages of 7 months and 6 years (mean age 2.7 years). ERG was detected to flash stimulus and VEP to flash and/or pattern-reversal stimulus.
RESULTS: In infants less than 1 year of age, retinal dysfunction was recognised in 36% of infants who had been diagnosed as Leber's congenital amaurosis, achromatopsia and retinal dystrophy; postretinal dysfunction was recognised in 32% of infants who had been diagnosed with ocular albinism, optic nerve hypoplasia and neurological nystagmus; retinal or postretinal function was normal in 7% of infants that had been diagnosed as congenital idiopathic nystagmus, while retinal function was normal and postretinal function was undefined in 25% of infants that had been diagnosed as optic nerve hypoplasia, neurological nystagmus and congenital idiopathic nystagmus. At follow-up the findings were: retinal dysfunction in 36%, postretinal dysfunction in 50% and normal retinal and postretinal function in 14% of children. All those children with normal retinal and postretinal function had been diagnosed as congenital idiopathic nystagmus.
CONCLUSIONS: Visual electrophysiological screening of infants with congenital nystagmus can establish or exclude retinal and postretinal pathway dysfunction. Therefore simultaneous skin ERG and VEP which is a non-invasive approach for infants enables an objective means for identifying the basis of congenital nystagmus, thereby assisting in its classification.

Entities:  

Mesh:

Year:  2004        PMID: 14744589     DOI: 10.1016/j.clinph.2003.10.011

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  7 in total

1.  VEP characteristics in children with achiasmia, in comparison to albino and healthy children.

Authors:  Jelka Brecelj; Maja Sustar; Nuška Pečarič-Meglič; Miha Skrbec; Branka Stirn-Kranjc
Journal:  Doc Ophthalmol       Date:  2012-02-21       Impact factor: 2.379

2.  VEP asymmetry with ophthalmological and MRI findings in two achiasmatic children.

Authors:  Jelka Brecelj; Branka Stirn-Kranjc; Nuska Pecaric-Meglic; Miha Skrbec
Journal:  Doc Ophthalmol       Date:  2007-01-13       Impact factor: 2.379

3.  The diagnosis and assessment of visual function in Singaporean children with electrophysiology: 10-year results.

Authors:  Anna C S Tan; LiYu Chen; Rena Png; Audrey Chia
Journal:  Doc Ophthalmol       Date:  2016-04-16       Impact factor: 2.379

4.  Light-adapted electroretinograms in optic nerve hypoplasia.

Authors:  Caroline Chaplin; Mark S Borchert; Cassandra Fink; Pamela Garcia-Filion; Daphne L McCulloch
Journal:  Doc Ophthalmol       Date:  2009-08-11       Impact factor: 2.379

5.  Predictive value of N95 waveforms of pattern electroretinograms (PERGs) in children with optic nerve hypoplasia (ONH).

Authors:  Daphne McCulloch; Pamela Garcia-Filion; Cassandra Fink; Anthony C Fisher; Antonio Eleuteri; Mark S Borchert
Journal:  Doc Ophthalmol       Date:  2017-08-09       Impact factor: 2.379

Review 6.  The syndrome of optic nerve hypoplasia.

Authors:  Mark Borchert; Pamela Garcia-Filion
Journal:  Curr Neurol Neurosci Rep       Date:  2008-09       Impact factor: 5.081

7.  Mydriasis-Free Flicker Electroretinograms in 204 Healthy Children Aged 0-18 Years: Reference Data From Two Cohorts.

Authors:  Ting Zhang; Jinglin Lu; Limei Sun; Songshan Li; Li Huang; You Wang; Zeyu Li; Liming Cao; Xiaoyan Ding
Journal:  Transl Vis Sci Technol       Date:  2021-11-01       Impact factor: 3.283

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.